1. Fahim FM, Saad K, Askar EA, et al. Growth parameters and vitamin D status in children with thalassemia major in upper Egypt. Int J Hematol Oncol Stem Cell Res. 2013;7(4):10–4.
2. Shawky RM, Kamal TM. Thalassemia intermedia: an overview. Egypt J Med Hum Genet. 2012;13:245–55.
3. Farmakis D, Giakoumis A, Polymeropoulos E, et al. Pathogenetic aspects of immune deficiency associated with beta-thalassemia. Med Sci Monit. 2003;9(1):RA19–22.
4. Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–93.
5. Ricerca BM, Di Girolamo A, Rund D. Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications. Mediterr J Hematol Infect Dis. 2009;1(1):e2009028.